Structure of tert-butyl 4-(6-(8-cyclopentyl-5-Methyl-7-oxo-6-(1-propoxyvinyl)-7,8-dihydropyrido[2,3-d]pyriMidin-2-ylaMino)pyridin-3-yl)piperazine-1-carboxylate CAS 866084-31-3

Iden­ti­fi­ca­tion

CAS Number

866084-31-3

Name

tert-butyl 4-(6-(8-cyclopentyl-5-Methyl-7-oxo-6-(1-propoxyvinyl)-7,8-dihydropyrido[2,3-d]pyriMidin-2-ylaMino)pyridin-3-yl)piperazine-1-carboxylate

Syn­onyms

1-Piper­azinecar­boxylic acid, 4-[6-[[6-(1-butoxyethenyl)-8-cyclopentyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl]amino]-3-pyridinyl]-, 1,1-dimethylethyl ester [ACD/​Index Name]
2-Methyl-2-propa­nyl 4-(6-{[6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl]amino}-3-pyridinyl)-1-piperazinecarboxylate [ACD/IUPAC Name]
2-Methyl-2-propanyl-4-(6-{[6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl]amino}-3-pyridinyl)-1-piperazincarboxylat [Ger­man] [ACD/IUPAC Name]
4-(6-{[6-(1-Butoxyvinyl)-8-cyclopentyl-5-méthyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl]amino}-3-pyridinyl)-1-pipérazinecarboxylate de 2-méthyl-2-propa­nyle [French] [ACD/IUPAC Name]
866084-31-3 [RN]
tert-butyl 4-(6-{[6-(1-butoxyethenyl)-8-cyclopentyl-5-methyl-7-oxo-7H,8H-pyrido[2,3-d]pyrimidin-2-yl]amino}pyridin-3-yl)piperazine-1-carboxylate
4-[6-[[6-(1-Butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl]amino]pyridin-3-yl]piperazine-1-carboxylic acid tert-butyl ester
DS-19152
MFCD18642713
tert-butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate

SMILES

CCC­COC(=C)c1c(c2cnc(nc2n(c1=O)C3CCCC3)Nc4ccc(cn4)N5CCN(CC5)C(=O)OC(C)(C)C)C

Std­InChI

InChI=1S/C33H45N7O4/c1-7-8-19-43-23(3)28-22(2)26-21-35-31(37-29(26)40(30(28)41)24-11-9-10-12-24)36-27-14-13-25(20-34-27)38-15-17-39(18-16-38)32(42)44-33(4,5)6/h13-14,20-21,24H,3,7-12,15-19H2,1-2,4-6H3,(H,34,35,36,37)

Std­InChIKey

SCWKOL­RZB­MGT­NT-UHF­F­­FAOYSA-N

Mol­e­c­u­lar Formula

C33H45N7O4

Mol­e­c­u­lar Weight

603.755

MDL Number

MFCD18642713

Prop­er­ties

Appear­ance

Light yel­low to brown powder

Safe­ty Data

Sym­bol

exclamation-mark-jpgGHS07

Sig­nal Word

Warn­ing

Haz­ard statements

H302-H315-H319-H335

Pre­cau­tion­ary Statements

P261-P305+P351+P338

WGK Germany

3

MSDS Download

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our tert-butyl 4-(6-(8-cyclopentyl-5-Methyl-7-oxo-6-(1-propoxyvinyl)-7,8-dihydropyrido[2,3-d]pyriMidin-2-ylaMino)pyridin-3-yl)piperazine-1-carboxylate CAS 866084-31-3

Iden­ti­fi­ca­tion Methods

IR

Puri­ty

99% min

Water

≤2%

Relat­ed substances

Inter­me­di­ate lV

≤0.2%

Debromi­na­tion intem­me­di­ate lV

≤0.2%

Impu­ri­ty C

≤1.0%

Any oth­er impurity

≤0.5%

Total impu­ri­ties

≤1.0%

Residue on Ignition

≤1%

N-Butyl Vinyl Ether

≤0.10%

N,N-diisopropylethylamin

≤0.10%

Acelone

≤0.5%

Dichloromethane

≤0.06%

Eth­yl­ac­etate

≤0.5%

Methylisobutyl ketone

≤0.45%

n-Hep­­­tane

≤0.5%

n-Buty­lal­­co­hol

≤0.5%

Toluepe

≤0.089%

Shelf Life

1 year

Stor­age

Known Appli­ca­tion

Tert-butyl 4-(6-(8-cyclopentyl-5-methyl-7-oxo-6-(1-propoxyvinyl)-7,8-dihydropyrido[2,3-d]pyrimidin-2-ylamino)pyridin-3-yl)piperazine-1-carboxylate is a com­plex phar­ma­ceu­ti­cal inter­me­di­ate com­mon­ly used in the devel­op­ment and syn­the­sis of anti-can­cer drugs. The compound’s struc­ture, which includes mul­ti­ple cyclic and het­e­ro­cyclic rings, allows it to tar­get spe­cif­ic enzymes or pro­teins, mak­ing it an essen­tial pre­cur­sor in cer­tain tar­get­ed can­cer ther­a­pies. Specif­i­cal­ly, this com­pound may work by affect­ing DNA syn­the­sis or pro­tein phos­pho­ry­la­tion path­ways in tumor cells, there­by inhibit­ing can­cer cell proliferation.

Gen­er­al View of Documents

This prod­uct is devel­oped by our R&D com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Lim­it­ed (http://​www​.cam​ing​.com/).

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you shortly.

























    Please prove you are human by select­ing the star.